Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03416127Phase 2Completed
Phase 2, randomised, double-blind trial (3 arms), sponsored by Universidad de Guadalajara. Primary endpoints: Fasting Serum Glucose at 12 weeks, 2 Hours After Oral Glucose Tolerance Test Glucose at 12 weeks and 1 more. Started Jan 2018; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03416127.